Immediate release pharmaceutical formulation of 4-[3-(4- cyclopropanecarbonyl-piperazine-1… Grant US-11633396-B2 United States of America 25 Apr 2023
Quinazolinone derivatives as PARP inhibitors Grant US-10150757-B2 United States of America 11 Dec 2018